HK-listed JD Health rises on tie-up focusing on cancer management

JD Health International

21/05/2021 06:20

** Shares of Chinese internet healthcare provider JD Health
International Inc  6618.HK  rise as much as 5.7% to HK$120,
their highest since May 6
    ** Stock last up 4.4%, on track for best session since April
28; the second-biggest pct gainer in Hang Seng Tech Index
 .HSTECH 
    ** Chinese oncology platform Genetron Holdings Ltd  GTH.O 
announces strategic partnership with JD Health to create
solutions for full-cycle cancer management, focusing on liver
and lung cancer in first phase of tie-up  urn:newsml:reuters.com:*:nFWN2N70FD
    ** Genetron says it will cooperate with the Hong Kong-listed
subsidiary of JD.com Inc  JD.O   9618.HK  to cover early cancer
screening, molecular profiling, therapy selection, and drug
resistance monitoring 
    ** JD.com's Hong Kong shares climb 3.9% to the highest since
May 10 
    ** The Hang Seng Tech Index  .HSTECH  rises 1.5%, and the
healthcare index  .HSCIH  surges 1.7%
    ** The Hang Seng China enterprises index  .HSCE  gains 0.5%,
while the benchmark index  .HSI  slips 0.1%
    ** As of last close, JD Health stock had dropped 24.3% this
year

 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)